Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial

DiscussionThe study will provide high-quality clinical evidence to support the efficacy and safety of Baidu Jieduan granules in the treatment of moderate COVID-19, and enrich the theory and practice of TCM in treating COVID-19.Trial registrationChinese Clinical Trial RegistryChiCTR2000029869. Registered on 15 February 2020
Source: Trials - Category: Research Source Type: clinical trials